NO20090264L - En regioselektiv palladiumkatalysert syntese av benzimidazoler og azabenzimidazoler - Google Patents

En regioselektiv palladiumkatalysert syntese av benzimidazoler og azabenzimidazoler

Info

Publication number
NO20090264L
NO20090264L NO20090264A NO20090264A NO20090264L NO 20090264 L NO20090264 L NO 20090264L NO 20090264 A NO20090264 A NO 20090264A NO 20090264 A NO20090264 A NO 20090264A NO 20090264 L NO20090264 L NO 20090264L
Authority
NO
Norway
Prior art keywords
azabenzimidazoles
benzimidazoles
regioselective
catalyzed synthesis
formula
Prior art date
Application number
NO20090264A
Other languages
English (en)
Norwegian (no)
Inventor
Matthias Urmann
Jorge Alonso
Andreas Lindenschmidt
Marc Nazare
Nils Halland
Omar Rkyek
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of NO20090264L publication Critical patent/NO20090264L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/10Radicals substituted by halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/08Radicals containing only hydrogen and carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/16Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO20090264A 2006-07-15 2009-01-16 En regioselektiv palladiumkatalysert syntese av benzimidazoler og azabenzimidazoler NO20090264L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06014789A EP1878724A1 (de) 2006-07-15 2006-07-15 Regioselektive, Palladium-katalysierte Synthese von Benzimidazolen und Azabenzimidazolen
PCT/EP2007/005816 WO2008009348A1 (en) 2006-07-15 2007-06-30 A regioselective palladium catalyzed synthesis of benzimidazoles and azabenzimidazoles

Publications (1)

Publication Number Publication Date
NO20090264L true NO20090264L (no) 2009-03-25

Family

ID=37564112

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20090264A NO20090264L (no) 2006-07-15 2009-01-16 En regioselektiv palladiumkatalysert syntese av benzimidazoler og azabenzimidazoler

Country Status (13)

Country Link
US (1) US8188282B2 (de)
EP (2) EP1878724A1 (de)
JP (1) JP5271264B2 (de)
KR (1) KR20090029267A (de)
CN (1) CN101490014B (de)
AT (1) ATE544757T1 (de)
AU (1) AU2007276514A1 (de)
BR (1) BRPI0714202A2 (de)
CA (1) CA2657717A1 (de)
IL (1) IL196431A0 (de)
MX (1) MX2009000276A (de)
NO (1) NO20090264L (de)
WO (1) WO2008009348A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8507473B2 (en) 2008-09-11 2013-08-13 Arena Pharmaceuticals, Inc. 3H-imidazo[4,5-b]pyridin-5-ol derivatives useful in the treatment of GPR81 receptor disorders
US8394969B2 (en) 2008-09-26 2013-03-12 Merck Sharp & Dohme Corp. Cyclic benzimidazole derivatives useful as anti-diabetic agents
EP2348857B1 (de) 2008-10-22 2016-02-24 Merck Sharp & Dohme Corp. Neue cyclische benzimidazolderivate als antidiabetika
EP2352374B1 (de) 2008-10-29 2014-09-24 Merck Sharp & Dohme Corp. Neue cyclische benzimidazolderivate als antidiabetika
US8329914B2 (en) 2008-10-31 2012-12-11 Merck Sharp & Dohme Corp Cyclic benzimidazole derivatives useful as anti-diabetic agents
JP2013520502A (ja) 2010-02-25 2013-06-06 メルク・シャープ・エンド・ドーム・コーポレイション 有用な抗糖尿病薬である新規な環状ベンズイミダゾール誘導体
MY170236A (en) 2010-10-06 2019-07-11 Glaxosmithkline Llc Benzimidazole derivatives as pi3 kinase inhibitors
US8952177B2 (en) 2013-03-15 2015-02-10 Janssen Pharmaceutica Nv 1,2,6-substituted benzimidazoles as FLAP modulators
US9682971B2 (en) 2013-03-15 2017-06-20 Janssen Pharmaceutica Nv 1,2,5-Substituted benzimidazoles as flap modulators
CN105017257B (zh) * 2014-04-30 2017-05-24 华东理工大学 四氢茚并吡咯并咪唑的衍生物及其制备方法和用途
US10385048B2 (en) 2014-12-31 2019-08-20 Syngenta Participation Ag Pesticidally active polycyclic derivatives with sulfur containing substituents
BR112017019326B1 (pt) * 2015-03-12 2022-04-26 Fmc Corporation Composto, composição e método para controlar uma praga invertebrada
JP6662901B2 (ja) * 2015-03-27 2020-03-11 シンジェンタ パーティシペーションズ アーゲー 殺微生物性二環式複素環式誘導体
DE102016000837A1 (de) 2016-01-27 2017-07-27 Giesecke & Devrient Gmbh Verfahren und Vorrichtung zur Untersuchung von Wertdokumenten
GB201617630D0 (en) 2016-10-18 2016-11-30 Cellcentric Ltd Pharmaceutical compounds
EP3562306B1 (de) 2016-12-29 2025-02-26 Ji Xing Pharmaceuticals Hong Kong Limited Metalloenzym-inhibitor-verbindungen
JP7227157B2 (ja) 2016-12-29 2023-02-21 フェーズバイオ ファーマシューティカルズ,インコーポレイテッド 金属酵素阻害剤化合物
MX388196B (es) 2017-04-26 2025-03-19 Basilea Pharm Int Ag Procesos para la preparacion de furazanobencimidazoles y formas cristalinas de estos.
TWI795440B (zh) 2017-09-15 2023-03-11 美商佛瑪治療公司 作為CBP/p300抑制劑之四氫─咪唑並喹啉化合物
GB201806320D0 (en) 2018-04-18 2018-05-30 Cellcentric Ltd Process
US10870648B2 (en) 2018-06-29 2020-12-22 Forma Therapeutics, Inc. Inhibiting CREB binding protein (CBP)
MX2021003904A (es) 2018-10-05 2021-10-26 Annapurna Bio Inc Compuestos y composiciones para el tratamiento de afecciones asociadas con la actividad del receptor apj.
JP2022516969A (ja) 2019-01-08 2022-03-03 フェーズバイオ ファーマシューティカルズ,インコーポレイテッド 金属酵素阻害剤化合物
WO2020190791A1 (en) 2019-03-15 2020-09-24 Forma Therapeutics, Inc. Inhibiting cyclic amp-responsive element-binding protein (creb)
US11801243B2 (en) 2020-09-23 2023-10-31 Forma Therapeutics, Inc. Bromodomain inhibitors for androgen receptor-driven cancers
US11795168B2 (en) 2020-09-23 2023-10-24 Forma Therapeutics, Inc. Inhibiting cyclic amp-responsive element-binding protein (CREB) binding protein (CBP)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA9610745B (en) * 1995-12-22 1997-06-24 Warner Lambert Co 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists
TWI245068B (en) * 2003-11-18 2005-12-11 Chi Mei Optoelectronics Corp Iridium complex as light emitting material and organic light emitting diode device
US7371743B2 (en) * 2004-02-28 2008-05-13 Boehringer Ingelheim International Gmbh Carboxylic acid amides, the preparation thereof and their use as medicaments
EP1695971A1 (de) * 2004-12-30 2006-08-30 Laboratorios Del Dr. Esteve, S.A. Substituierte Phenylpiparazinverbindungen, deren Herstellung und Verwendung in Medikamenten

Also Published As

Publication number Publication date
EP2044033A1 (de) 2009-04-08
WO2008009348A1 (en) 2008-01-24
EP2044033B1 (de) 2012-02-08
IL196431A0 (en) 2009-09-22
EP1878724A1 (de) 2008-01-16
MX2009000276A (es) 2009-01-26
CN101490014B (zh) 2011-12-14
ATE544757T1 (de) 2012-02-15
US8188282B2 (en) 2012-05-29
CN101490014A (zh) 2009-07-22
US20090203912A1 (en) 2009-08-13
CA2657717A1 (en) 2008-01-24
JP2009544589A (ja) 2009-12-17
AU2007276514A1 (en) 2008-01-24
KR20090029267A (ko) 2009-03-20
BRPI0714202A2 (pt) 2013-02-19
JP5271264B2 (ja) 2013-08-21

Similar Documents

Publication Publication Date Title
NO20090264L (no) En regioselektiv palladiumkatalysert syntese av benzimidazoler og azabenzimidazoler
MX2009013753A (es) Una sintesis regioselectiva catalizada por cobre de bencimidazoles y azabencimidazoles.
ATE537142T1 (de) Übergangsmetallkatalysierte synthese von n- aminoindolen
ATE538120T1 (de) Regioselektive, metallkatalysierte synthese annelierter benzimidazole und azabenzimidazole
MX2009014203A (es) Una sintesis de 2h-indazoles catalizada por un metal de transicion.
TNSN08372A1 (en) Heterocyclic amides for use as pharmaceuticals
MX2013002233A (es) Agente de control de plagas.
TW200617009A (en) Organic compounds
AR058403A1 (es) PIRIMIDINILOXI Y PIRIDINILOXI UREAS SUSTITUíDAS COMO INHIBIDORES DE PROTEíNA QUINASAS, COMPOSICIONES FARMACÉUTICAS QUE LAS CONTIENEN Y SU USO EN LA PREPARACIoN DE UN MEDICAMENTO PARA EL TRATAMIENTO DE ENFERMEDADES MEDIADAS POR LA ACTIVIDAD BASAL DE B-RAF.
DE602008002843D1 (de) Neue antimikrobielle verbindungen, ihre synthese und ihre verwendung zur behandlung von säugetierinfektionen
WO2008063781A3 (en) Chemical compounds as cannabinoid receptor ligands
ZA200810739B (en) Pesticide containing novel pyridyl-methanamine derivative or its salt
WO2008079683A3 (en) N- (5, 6, 7, 8-tetrahydronaphthalen-1-yl) urea derivatives and related compounds as trpv1 vanilloid receptor antagonists for the treatment of pain
MX2009013738A (es) Un procedimiento catalizado por paladio para el acoplamiento de alquinos terminales con tosilatos de arilo.
DE602007000376D1 (de) Katalytisches Eintopfverfahren zur Synthese von Isocyanaten
ATE449082T1 (de) (3,4-dihydro-chinazolin-2-yl)-(2-aryloxy-ethyl) amine mit aktivität am 5-ht-rezeptor
TW200744996A (en) Improved process for the production of nitroisourea derivative
MY151461A (en) A process for the palladium-catalyzed coupling of terminal alkynes with heteroayl tosylates and heteroaryl benzenesulfonates
NO20081862L (no) Alkylsulfoksidkinoliner som NK-3-reseptorligander
ATE549316T1 (de) Piperidinderivate als nk3-rezeptorantagonisten
MX2007007554A (es) Oxiarenos sustituidos.
FR2915994B1 (fr) Procede de synthese de l'acide (z)-3-[2-butoxy-3'-(3-heptyl-1-methyl-ureido)-biphenyl-4-yl] -2-methoxy-acrylique.
TH83578B (th) อิมิดาโซลที่ถูกแทนที่ด้วยเฮทเทอโรไซคลิลเอไมด์
TH107343A (th) อนุพันธ์มัลทิ-ไซคลิคซีนแนมีด
TH75305A (th) อนุพันธ์ 7-ฟีนิลอะมิโน-4-ควิโนโลน-3-คาร์บอกซิลิคแอซิด, กรรมวิธีสำหรับการเตรียมสารเหล่านี้ และการใช้สารเหล่านี้เป็นยา

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application